NSIM
AGIO icon

North Star Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

North Star Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-125
Closed -$3.65K – 1165
2024
Q1 		$3.65K Buy
+125
New +$3.35K ﹤0.01% 1021
2022
Q1 		– Sell
-125
Closed -$4K – 1144
2021
Q4 		$4K Buy
+125
New +$5.03K ﹤0.01% 1011

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

North Star Investment Management's AGIO Position: Q2 2024 in Review

North Star Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2024, closing a stake of 125 shares — an estimated $3.65K sold.

North Star Investment Management first reported a position in AGIO in Q4 2021 and held it in 2 quarters. The position peaked at $4K in Q4 2021. 205 funds tracked by Wall St. Rank hold AGIO as of Q2 2024.

  • North Star Investment Management reported no remaining Agios Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • North Star Investment Management sold 125 Agios Pharmaceuticals shares in Q2 2024, an estimated $3.65K.
  • North Star Investment Management first reported a position in Agios Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • North Star Investment Management's Agios Pharmaceuticals position peaked at $4K in Q4 2021.
  • 205 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2024.

Based on North Star Investment Management's 13F filing for Q2 2024, filed 6 Aug 2024.